Kent A. Kirchner

Nephrology

1500 E Woodrow Wilson Ave
Jackson, MS 39216

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5 publications

Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINT.

Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINT.

Journal: Journal of the American Society of Nephrology : JASN

Published: December 22, 2018

Effect of Intensive Blood-Pressure Treatment on Patient-Reported Outcomes.

Effect of Intensive Blood-Pressure Treatment on Patient-Reported Outcomes.

Journal: The New England journal of medicine

Published: August 24, 2017

Chronic Kidney Disease Classification in Systolic Blood Pressure Intervention Trial: Comparison Using Modification of Diet in Renal Disease and CKD-Epidemiology Collaboration Definitions.

Chronic Kidney Disease Classification in Systolic Blood Pressure Intervention Trial: Comparison Using Modification of Diet in Renal Disease and CKD-Epidemiology Collaboration Definitions.

Journal: American journal of nephrology

Published: June 13, 2016

Reversibility of fenofibrate therapy-induced renal function impairment in ACCORD type 2 diabetic participants.

Reversibility of fenofibrate therapy-induced renal function impairment in ACCORD type 2 diabetic participants.

Journal: Diabetes care

Published: March 21, 2012

Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience.

Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience.

Journal: Diabetologia

Published: September 28, 2011

Showing 1-5 of 5

Last Updated: 09/26/2026